Breast Cancer Treatment in Istanbul: Why Choose Turkey?
Istanbul has emerged as a leading destination for breast cancer treatment, combining JCI-accredited oncology centers with costs 60-75% lower than the UK, Germany, or USA. Multidisciplinary tumor boards, advanced molecular diagnostics, and English-speaking oncologists make Istanbul a viable option for international patients.
How much does breast cancer treatment cost in Istanbul?
A full breast cancer treatment course in Istanbul costs $8,000–$25,000 depending on cancer stage and treatment protocol. This compares to £30,000–£80,000 in the UK and $50,000–$150,000 in the USA. The cost difference reflects Turkey's lower operational costs, not lower quality standards.
What breast cancer treatments are available?
Istanbul's oncology centers offer the complete treatment spectrum: breast-conserving surgery (lumpectomy), mastectomy with reconstruction, sentinel lymph node biopsy, chemotherapy, targeted therapy (Herceptin, CDK4/6 inhibitors, PARP inhibitors), hormone therapy, and radiotherapy.
JCI-Accredited Breast Cancer Centers in Istanbul
Acibadem, Memorial, Medipol, and Florence Nightingale hospitals hold JCI accreditation and have dedicated breast oncology units with tumor boards that meet weekly to review complex cases. All follow ESMO and NCCN treatment guidelines.
HER2-Positive and Triple-Negative Breast Cancer
Istanbul centers offer targeted therapy for HER2-positive breast cancer including trastuzumab, pertuzumab, and T-DM1 at 50-60% lower cost than the UK. For triple-negative breast cancer, immunotherapy with pembrolizumab is available at select centers.
